Table 2. Clinical and immunophenotypic... | American Society of Hematology

Table 2.

Clinical and immunophenotypic characteristics of patients with hairy cell leukemia

Patient No.	Age/gender	Therapy^*	CD19^†	SmIg	κ/λ	CD11c	CD103	CD20	CD25	FMC7	CD79β
42	57/M	No	28	25	λ	21	20	16	28	21	27
83	30/F	No	63	86	κ	63	77	76	77	67	87
93	55/M	IFN-α	63	74	λ	63	63	76	63	79	79
103	59/M	No	65	67	λ	65	65	65	68	68	68
163	45/F	No	45	56	κ	44	37	56	54	38	43

Patient No.	Age/gender	Therapy^*	CD19^†	SmIg	κ/λ	CD11c	CD103	CD20	CD25	FMC7	CD79β
42	57/M	No	28	25	λ	21	20	16	28	21	27
83	30/F	No	63	86	κ	63	77	76	77	67	87
93	55/M	IFN-α	63	74	λ	63	63	76	63	79	79
103	59/M	No	65	67	λ	65	65	65	68	68	68
163	45/F	No	45	56	κ	44	37	56	54	38	43

SmIg indicates surface membrane Ig; IFN, interferon.

Treatment at the time when material was obtained for phenotypic and molecular immunoglobulin studies.

Percentage of positive cells in the mononuclear cell fraction.